Digital Transformation webinar series
25 June 2024
Episode 1 – Regulating AI – the European Approach and the APAC Perspective
Analysis of IP landscape (Greater China focus): update on patents and patent licensing, and current trends in trademarks, including insights from INTA Conference 2024
[Osaka] Tuesday, 4 June 2024 / [Tokyo] Wednesday, 5 June 2024
The Hogan Lovells Asia Pacific IPMT team invites you to join our intellectual property (IP) seminar on either 4 June in Osaka or 5 June in Tokyo.
Hogan Lovells APAC Life Sciences and Health Care Webinar Series - Spotlight on the U.S. - Session 3
14 May 2024 | 10:00 a.m. - 11:00 a.m. (CST)| 11:00 a.m. - 12:00 p.m. (JST) | 12:00 p.m. - 1:00 p.m. (AEST) | 10:00 p.m. - 11:00 p.m. (EDT - Monday, 13 May 2024)
Webinar No. 2: Preparing for the BIOSECURE Act
Hogan Lovells APAC Life Sciences and Health Care Webinar Series - Spotlight on the U.S. - Session 2
18 January 2024 | 10:00 a.m. - 11:00 a.m. (CST)
Webinar No. 2: Life Sciences companies navigating the impact of the U.S. Inflation Reduction Act
Antitrust year-in-review and a look forward to 2024
13 December 2023
Join the Hogan Lovells Antitrust and Competition team on Wednesday, 13 December 2023 where we will look back at the major competition-related events of 2023 and what we can expect next...
Launch Seminar: Hogan Lovells Asia Pacific Data Protection and Cyber Security Guide 2023
1 June 2023 | 12:15 p.m. - 2:00 p.m. (GMT +8)
Data protection and cyber security compliance has become a critical area for management focus in the Asia-Pacific (“APAC”) region.
APAC Life Sciences and Health Care Webinar Series - Spotlight on Greater China - Session 5
04 April 2023 | 9:00 a.m. - 10:30 a.m. CET | 3:00 p.m. - 4:30 p.m. CST/HKT | 4:00 p.m. - 5:30 p.m. JST
Webinar No. 5: How to navigate antitrust and regulatory risks in life sciences distribution channels in Greater China
APAC Life Sciences and Health Care Webinar Series - Spotlight on Greater China
17 May 2022 - 4 April 2023
Companies in the life sciences and health care industry continue to navigate unparalleled challenges during the COVID-19 pandemic while also seeking to balance commercial opportunities and...
